Total planned funding: $1,333,150,473
Clear active filters
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $343,013,868 |
Zambia | $198,860,568 |
Tanzania | $169,118,701 |
Mozambique | $128,401,433 |
Côte d'Ivoire | $83,620,657 |
Zimbabwe | $72,296,922 |
Ethiopia | $61,593,077 |
Rwanda | $60,921,893 |
Uganda | $53,779,030 |
Haiti | $37,081,995 |
Vietnam | $35,625,620 |
Kenya | $35,216,278 |
Democratic Republic of the Congo | $16,140,079 |
Cameroon | $10,136,747 |
South Africa | $9,207,710 |
Guyana | $5,374,525 |
Botswana | $4,335,118 |
Namibia | $3,239,092 |
Burundi | $2,599,423 |
Eswatini | $1,906,218 |
Malawi | $300,000 |
South Sudan | $214,638 |
Ukraine | $132,881 |
Angola | $34,000 |
Lesotho | $0 |
Organizational Types
Private Contractor | $1,333,150,473 |
Program Areas
Treatment | $1,333,150,473 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,333,150,473 |
Top Partner Programs
Chemonics International:
$373,400,880
View countries